TNG Pharmaceuticals, Inc. — Form D

TNG Pharmaceuticals, Inc. of LOUISVILLE, KY, a company, filed a Form D exempt-offering notice with the SEC on 2013-08-05. The offering totals $4.5M, of which $2.6M was reported sold. Industry: Other.

Offering

• Filed: 2013-08-05
• Form: D
• Accession: 0000911959-13-000034
• Industry: Other
• Exemptions: 06
• Total offering: $4.5M
• Amount sold: $2.6M
• Remaining: $1.9M
• Investors: 22
• Date of first sale: 2013-08-02
• Security types: equity
• Revenue range: No Revenues
• SEC file number: 021-200715

Issuer

• Name: TNG Pharmaceuticals, Inc.
• CIK: 0001583185
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2011
• Address: 201 E JEFFERSON STREET, LOUISVILLE, KY, 40202
• Phone: 888-345-0878

Officers, directors & promoters (8)

More

• CIK 1583185 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search